TrialJournal of neuro-oncology2019

Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.

Sara Pedretti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.